Dr Mark Harries
Transparency under the CMA Order 2014
All private healthcare operators are required under the Competition and Markets Authority Order 2014 (“The CMA Order”) to be transparent about the relationship between their doctor and the private healthcare operator. Therefore, prospective patients should be aware that (in addition to being permitted to consult with and to treat patients at our facilities) this doctor also has an advisory role with HCA UK and is paid by HCA UK for this advisory role. We describe the nature of the role below, and we indicate how much the doctor has been paid for performing the role since 1 January 2023
Dr Harries provides medical advisory services for HCA's London Bridge Hospital and Leaders in Oncology Care. In his role, Dr Harries leads interactions with hospital medical staff and the hospital leadership team to assist the hospital by providing medical advice and promote high quality, cost effective care.
In his role, he contributes to the strategy, policies and decision making regarding oncology treatments and advises HCA to ensure that care provided within the facility is appropriate and efficient. In his role, Dr Harries advises on initiatives to drive clinical standards by providing professional advice on clinical governance matters and ensuring the adoption of those by colleagues in the oncology area.
In addition, he works with medical insurance companies, GPs, other relevant local NHS contacts, and patients to educate and advise on relevant clinical updates to treatments in oncology available in the facility. Furthermore, he advises on the accuracy of literature that may be published regarding relevant services. He will also advise on how to make the patient referral smooth to reduce stress and anxiety for patients.
As well as promoting successful working of the facility's Medical Advisory Committee, Integrated Governance Committee and advising the hospital's senior management team on all matters relating to oncology practice within the facility, Dr Harries is responsible for providing advice on clinical governance matters relating to oncology to conform with national standards and recommend new programmes to drive up clinical standards.
In addition, he supports the HCA team to recruit and retain staff as well as taking a lead role in medical staff credentialing. In his role, he will evaluate ongoing quality initiatives such as clinical audits and quality assurance programmes.
Dr Harries leads the facility's multi-disciplinary team, to bring together clinical teams, to discuss the quality of care and decide the most appropriate treatment pathways for patients.
Dr Harries is the "Lead Clinician" for the oncology service and as such represents the Centre at medical conferences and other local, national or international meetings with clinical and academic experts.
Dr Harries is supervisor for an Independent Prescribing Pharmacist to ensure improved delivery of systemic therapy.
HCA UK is charged by doctors in return for their expertise and advice, including on how to operate safe hospital facilities delivering complex care. All services provided under this agreement are charged to HCA UK. In 2023 the total paid for these services was £19,764.
If a doctor provides HCA UK with medical advisory services and also practises in the NHS, HCA UK requires that doctor to attest that he/she is not compromising his/her NHS commitments in so doing.